Today prescription drugs are prescribed every day for pain, mental, emotional, or other illnesses. They are given a set of directions from the doctor for how much and how long to take them. After the prescribed dosage is up, the user should stop taking the drug for that initial incident. However, some patients get dependent on the drug whether they had more refills than necessary or took more than the recommended dosage.
Xanax is the most commonly prescribed and misused benzodiazepine used to treat anxiety and panic disorders. This drug is a central nervous system depressant and can lead to feelings of calm and relaxation. According to the National Health Statistics Reports during 2014–2016, benzodiazepines were prescribed at approximately 65.9 million office-based physician visits. The rates for women prescribed the drug were also higher than the men (at 34 visits per 100 women).
When Pregnant Women Take Xanax
When a woman is pregnant, every choice she makes can affect the baby inside her; from emotional stress to the food she eats and especially the medication she takes. So many of her choices can have an impact on the developing baby. For example, medications like Xanax are known to go through the placenta. The placenta is an organ that develops in your uterus during pregnancy. This structure provides oxygen and nutrients to your growing baby, which means that taking Xanax can directly affect the fetus. If a pregnant woman takes this drug, the fetus is at risk for conditions like withdrawal and congenital disabilities.
Can Abusing Xanax Affect A Pregnancy?
Abusing Xanax can affect a women’s pregnancy. It can lead to dependence, addiction, maternal and neonatal withdrawal, and congenital disabilities when taken while pregnant. In addition, Xanax can lead to congenital disabilities and withdrawal in babies. Unfortunately, even though this has been researched, up to 33 percent of women still receive drugs like Xanax while pregnant. Usually, this drug has been prescribed to the women for some condition that occurred before the pregnancy.
Because of Xanax’s ability to cause dependency when abused and taken more than prescribed, many women still take it even though Xanax use can put the baby at risk. In addition, when people are dependent on Xanax, they may abuse the substance by taking larger or more frequent doses than prescribed.
What Are The Actual Risks To The Baby During Xanax Addiction?
- Birth Defects
Just like any other drug or alcohol, if a pregnant woman abuses Xanax in the first trimester, the baby could be born with congenital disabilities like cleft palate or inguinal hernia. In addition, some researchers have also discovered a relation between prenatal Xanax abuse and the baby’s head being too small around. This is called microcephaly. Some babies are also born with congenital hip dislocation.
- Neonatal Abstinence Syndrome (Withdrawal)
One of the most known risks of Xanax addiction while pregnant is neonatal abstinence syndrome or neonatal withdrawal. If a person takes Xanax throughout their pregnancy, just like if the mother were to stop abruptly and start to go into withdrawals, the baby could also be born suffering from withdrawal.
Signs Of Xanax Withdrawal Symptoms
Xanax is known to have difficult withdrawals. Even among healthy adults, withdrawing from Xanax can lead to life-threatening symptoms such as a seizure. For a newborn baby, these symptoms can be extremely dangerous and even deadly. Symptoms of neonatal abstinence syndrome (withdrawal) include:
- difficulty sleeping
- sedation
- irritability (excessive crying)
- low heart rate
- trouble sucking/eating
- uneven breathing
- floppy infant syndrome (low muscle tone in head, arms, and legs)
- cyanosis (bluish tint to the skin)
- seizures
How To Avoid Your Baby Having Risks From Xanax
If a baby is born addicted to Xanax, they will likely suffer from symptoms of neonatal abstinence syndrome. This could interfere with maternal-child bonding. Additionally, babies who suffer from neonatal abstinence syndrome may also face long-term risks to their health.
To avoid these long-term risks, it’s vital to stop using Xanax as soon as you learn you are pregnant. The safest way to stop taking Xanax is with the help of a medically assisted detox program.
Start Xanax Treatment Program At Aria Fl
At Addiction Recovery Institute of America, we can help. Xanax addiction is a serious chemical dependency that requires clinical supervision to ensure that a person can safely detox. At ARIA, we have medically-assisted detox programs that provide replacement and comfort medication to ease withdrawal symptoms.
Our Xanax detox in West Palm Beach, Florida, is overseen by an experienced clinical staff that specializes in Xanax addiction recovery. Every person admitted into our comfortable Xanax detox unit will be under the care of state-licensed clinicians, psychiatrists, counselors, and therapists. In addition, each staff member of our cross-disciplinary team works to ensure that our clients are monitored around the clock. So call us and begin healing safely from addiction today.
FAQs About Side Effects Of Xanax Addiction During Pregnancy
Q: What are the side effects of Xanax addiction during pregnancy?
The side effects of Xanax addiction during pregnancy affect both the mother and the developing baby and can range from serious to life-threatening. For the mother, Xanax addiction during pregnancy carries risks of increased sedation and impaired coordination (raising the risk of falls and accidents), respiratory depression (slowed breathing that can reduce oxygen delivery to the fetus), worsening dependency as the body builds tolerance and requires higher doses to achieve the same calming effect, severe withdrawal symptoms if the drug is reduced or stopped abruptly (including seizures, which can be fatal for both mother and baby), malnutrition and poor prenatal care (common in active addiction), increased risk of miscarriage, and complications during labor and delivery. For the baby, the side effects of Xanax addiction during pregnancy include an increased risk of congenital birth defects when used during the first trimester (including cleft palate, inguinal hernia, and microcephaly), neonatal abstinence syndrome (withdrawal symptoms in the newborn), floppy infant syndrome (low muscle tone in the head, arms, and legs), low birth weight, premature birth, lower Apgar scores at delivery, respiratory distress, difficulty feeding, and potential long-term developmental concerns. Because Xanax crosses the placenta directly, every dose the mother takes also reaches the developing fetus, making the baby physically dependent on the drug before birth.
Q: Can taking Xanax during pregnancy cause birth defects?
Yes, research has linked Xanax (alprazolam) use during pregnancy — particularly during the first trimester when the baby’s organs are forming — to an increased risk of certain congenital birth defects. The FDA classifies Xanax as a Category D pregnancy drug, meaning there is positive evidence of human fetal risk based on clinical data. Specific birth defects associated with first-trimester Xanax exposure include cleft lip and cleft palate (a gap or split in the upper lip or roof of the mouth that affects feeding, speech, and dental development), inguinal hernia (a condition where tissue protrudes through a weak spot in the abdominal muscles in the groin area), microcephaly (a condition where the baby’s head is significantly smaller than expected, which can affect brain development), and congenital cardiac defects (heart abnormalities). Some studies have also reported an association between benzodiazepine use during pregnancy and congenital hip dislocation. It is important to note that while these associations have been identified, the absolute risk for any individual pregnancy depends on many factors including the dose, duration of use, timing of exposure, and the mother’s overall health. However, the risk is significantly amplified in cases of Xanax addiction, where the drug is being taken in higher-than-prescribed doses or throughout multiple trimesters. If you are pregnant or planning to become pregnant and currently taking Xanax, consult your prescribing physician immediately — do not stop taking it abruptly.
Q: What is neonatal abstinence syndrome from Xanax?
Neonatal abstinence syndrome (NAS) is a group of withdrawal symptoms that a newborn baby experiences after being exposed to addictive substances — including Xanax (alprazolam) — in the womb. Because Xanax crosses the placenta, if a mother takes it regularly during pregnancy, the fetus becomes physically dependent on the drug. When the baby is born and the supply of Xanax is suddenly cut off, the newborn’s body goes through withdrawal, just as an adult would. Symptoms of neonatal abstinence syndrome from Xanax typically appear within the first 24 to 72 hours after birth, though benzodiazepine withdrawal can sometimes have a delayed onset appearing up to a week or more later. Symptoms include excessive and high-pitched crying, irritability and agitation, tremors and uncontrollable shaking, difficulty sleeping, poor feeding and weak sucking reflex, low heart rate (bradycardia), uneven or rapid breathing, floppy infant syndrome (hypotonia — reduced muscle tone in the head, arms, and legs causing the baby to appear limp), cyanosis (a bluish tint to the skin indicating inadequate oxygen), and in severe cases, seizures that can be life-threatening. Neonatal abstinence syndrome can also interfere with critical maternal-child bonding during the first weeks of life and may require extended hospitalization in a neonatal intensive care unit (NICU) where the baby is treated with supportive care and, in some cases, medications to safely manage the withdrawal process.
Q: Can you stop taking Xanax cold turkey while pregnant?
No — you should never stop taking Xanax abruptly (“cold turkey”) while pregnant. This is one of the most critical safety warnings regarding Xanax and pregnancy. Sudden discontinuation of benzodiazepines like Xanax can trigger severe and potentially life-threatening withdrawal symptoms in the mother, including grand mal seizures, severe rebound anxiety and panic attacks, psychosis, hallucinations, dangerously elevated heart rate and blood pressure, tremors, insomnia, and intense agitation. These withdrawal complications can be just as dangerous to the pregnancy as the drug itself — seizures during pregnancy can cause placental abruption (the placenta separating from the uterine wall), reduced oxygen supply to the fetus, premature labor, and even fetal death. The safe approach to stopping Xanax during pregnancy is a medically supervised taper, where your doctor gradually reduces your dose over a period of weeks or months, allowing both your body and the baby’s body to adjust to lower levels of the drug without triggering dangerous withdrawal. This tapering process should only be conducted under the direct supervision of a healthcare provider — ideally one experienced in both obstetrics and addiction medicine. At ARIA, our medically-assisted detox programs are designed to help pregnant women safely discontinue Xanax under 24-hour clinical supervision, with replacement and comfort medications to ease withdrawal symptoms while protecting both mother and baby.
Q: What are the risks of Xanax addiction during pregnancy for the mother?
Xanax addiction during pregnancy poses significant health risks to the mother that extend well beyond the direct effects of the drug itself. Physical health risks include respiratory depression (Xanax suppresses the central nervous system, slowing breathing — which can reduce oxygen delivery to both the mother and fetus), increased sedation leading to falls, accidents, and injuries during pregnancy, cardiovascular complications including low blood pressure and irregular heart rate, dangerous withdrawal symptoms if the drug is reduced or stopped without medical supervision (including life-threatening seizures), and an increased risk of pregnancy complications such as miscarriage, preterm labor, and placental insufficiency. Psychological and behavioral risks are equally severe — women struggling with Xanax addiction during pregnancy often experience worsening anxiety and depression (the conditions Xanax was originally prescribed to treat), isolation and shame that prevent them from seeking prenatal care, polydrug use (using other substances like alcohol or opioids alongside Xanax, which dramatically increases the danger), impaired judgment and decision-making, and damaged relationships with family and support systems. The compounding effect of addiction — where the body requires increasingly higher doses to achieve the same calming effect — means that pregnant women with untreated Xanax addiction are often exposing their babies to escalating levels of the drug throughout the pregnancy. This is why early intervention through a specialized addiction treatment program is critical for protecting the health of both mother and baby.
Q: What is floppy infant syndrome from Xanax?
Floppy infant syndrome — clinically known as neonatal hypotonia — is a condition characterized by abnormally low muscle tone in a newborn baby. It is a recognized side effect of prenatal benzodiazepine exposure, including Xanax (alprazolam), particularly when the drug is used in the later stages of pregnancy or at high doses. A baby born with floppy infant syndrome appears limp and has noticeably reduced muscle tension in the head, neck, arms, and legs. When picked up, the infant may feel unusually “floppy” and lack the normal resistance and reflexive movements that healthy newborns exhibit. The condition occurs because benzodiazepines like Xanax cross the placenta and accumulate in the fetus’s system. Since Xanax is a central nervous system depressant, it suppresses the baby’s neurological activity and muscle responsiveness. Additional symptoms often seen alongside floppy infant syndrome include excessive sedation (the baby is abnormally sleepy and difficult to rouse), weak or absent sucking reflex (making feeding extremely difficult), shallow or irregular breathing, and decreased responsiveness to stimulation. The good news is that floppy infant syndrome from benzodiazepine exposure is generally considered temporary — symptoms typically improve over the first few weeks of life as the drug is cleared from the baby’s system. However, these critical early weeks can be medically complex, often requiring NICU monitoring, assisted feeding, and respiratory support. In severe or prolonged cases, developmental follow-up may be recommended to ensure the baby meets physical and neurological milestones.
Q: Is it safe to take Xanax while breastfeeding?
Xanax (alprazolam) is excreted into breast milk, which means it can be transferred to the nursing infant during breastfeeding. Because of this, most medical professionals advise caution or recommend alternatives. While the amount of Xanax that reaches the baby through breast milk is relatively small, newborns and infants — especially premature babies — are significantly more sensitive to the effects of benzodiazepines than adults because their livers and kidneys are not yet fully developed and cannot efficiently metabolize the drug. Potential side effects of Xanax exposure through breast milk include excessive sedation (the baby becomes abnormally sleepy), poor feeding and weak sucking reflex, irritability, failure to gain weight at a healthy rate, and respiratory depression. Alprazolam has a half-life of approximately 11 to 15 hours, meaning that regular or repeated doses can cause the drug to accumulate in the infant’s system over time, compounding these risks. If benzodiazepine treatment is medically necessary for the mother, many experts prefer shorter-acting alternatives like lorazepam or oxazepam, which are less likely to accumulate in the baby. Some healthcare providers may also recommend timing doses immediately after breastfeeding sessions to minimize the concentration of the drug in the next feeding. However, for women with a history of Xanax addiction, the safest approach is to explore non-benzodiazepine alternatives — such as SSRIs (selective serotonin reuptake inhibitors) for anxiety or cognitive behavioral therapy (CBT) — and to discuss the decision with both an OB-GYN and a pediatrician.
Q: Are there safer alternatives to Xanax for anxiety during pregnancy?
Yes, there are several alternatives to Xanax that are generally considered safer for managing anxiety during pregnancy, though all medication decisions should be made in close consultation with your OB-GYN or a psychiatrist who specializes in perinatal mental health. Non-medication approaches are widely recommended as first-line treatments for anxiety during pregnancy. Cognitive Behavioral Therapy (CBT) is the most extensively studied and effective psychological treatment — it teaches practical skills for identifying and changing the thought patterns that fuel anxiety, and it carries zero risk to the developing baby. Other evidence-based non-pharmacological approaches include mindfulness-based stress reduction (MBSR), prenatal yoga, regular physical exercise appropriate for pregnancy, deep breathing and progressive muscle relaxation techniques, and structured support groups. When medication is necessary because anxiety is severe enough to impact the mother’s health or the pregnancy, certain selective serotonin reuptake inhibitors (SSRIs) — such as sertraline (Zoloft) — are often preferred over benzodiazepines like Xanax. SSRIs have been studied more extensively in pregnant populations and are generally considered to have a more favorable risk profile, though they are not without risks and require monitoring. The critical point is that untreated severe anxiety during pregnancy also carries risks — including increased cortisol levels that can affect fetal development, preterm labor, low birth weight, and postpartum depression — so the goal is to find the safest effective treatment, not simply to stop all treatment.
Q: Can Xanax cause long-term developmental problems for the baby?
The question of whether prenatal Xanax exposure causes permanent long-term developmental problems is an active area of ongoing research, and current evidence is mixed but concerning. Some studies have identified associations between prenatal benzodiazepine exposure and a range of developmental outcomes in children, including impaired gross motor skill development, internalizing behavioral problems (anxiety and withdrawn behavior), attention difficulties and traits associated with ADHD, lower academic achievement, and speech and language delays. However, researchers caution that it is scientifically difficult to isolate the effects of Xanax itself from other contributing factors. Mothers who take Xanax during pregnancy often have underlying anxiety or panic disorders, which themselves can affect fetal development through elevated cortisol and stress hormones. Additionally, environmental factors, genetic predisposition, polydrug use, and the quality of postnatal care all influence a child’s developmental trajectory. Some larger, more recent studies using rigorous methodologies (such as sibling-controlled comparisons) have found that when these confounding factors are accounted for, the direct link between benzodiazepine exposure and neurodevelopmental disorders diminishes. What is clear, however, is that the short-term risks — neonatal abstinence syndrome, floppy infant syndrome, respiratory depression, feeding difficulties, and low birth weight — are well-documented and clinically significant. Babies born with these conditions may require extended NICU stays and ongoing developmental monitoring. The safest approach is to minimize fetal exposure through medically supervised treatment for Xanax addiction during pregnancy.
Q: How can a pregnant woman get help for Xanax addiction?
Getting help for Xanax addiction during pregnancy requires specialized medical care that addresses both the addiction and the unique safety considerations of pregnancy — and the most important first step is reaching out for professional help as soon as possible. Pregnant women should never attempt to quit Xanax on their own, as benzodiazepine withdrawal can trigger seizures and other life-threatening complications that endanger both the mother and the baby. The treatment process typically begins with a comprehensive medical assessment that evaluates the severity of the Xanax dependency, the stage of pregnancy, any co-occurring mental health conditions (such as the anxiety or panic disorder for which Xanax was originally prescribed), and overall maternal and fetal health. From there, the treatment team — which should include addiction medicine specialists, OB-GYN physicians, and mental health professionals — will create a personalized tapering plan to gradually reduce Xanax intake under medical supervision, minimizing withdrawal risks for both mother and baby. Medically-assisted detox programs provide 24-hour clinical monitoring with replacement and comfort medications to manage withdrawal symptoms safely. Following detox, ongoing treatment through inpatient or outpatient programs helps address the psychological roots of addiction through evidence-based therapies including CBT, dialectical behavior therapy, and individual and group counseling. At the Addiction Recovery Institute of America (ARIA) in West Palm Beach, Florida, our experienced clinical staff specializes in safe Xanax detox and addiction recovery. Every client admitted into our detox program is under the care of state-licensed clinicians, psychiatrists, counselors, and therapists who monitor them around the clock to ensure the safest possible recovery for both mother and baby.